Literature DB >> 33124455

Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy.

A Gaspar1, J Silva2, A Calderon1, V Di Placido1, Z Vizintin3.   

Abstract

Objective: The aim of this study was to evaluate the effect of non-ablative erbium vaginal laser treatment on vaginal mucosa tissue affected by severe atrophy.
Methods: Ten patients with severe genitourinary syndrome of menopause were treated with two sessions of the non-ablative erbium-doped yttrium aluminium garnet laser (Er:YAG laser) separated by 4 weeks. Vaginal biopsies were performed before and 3 months after the second treatment. The improvement in vaginal atrophy was assessed using multiple measuring tools before and 6 months after the treatment. The degree of patients' satisfaction was also assessed.
Results: Microscopic examination showed significant changes in the main structural components of the vaginal wall mucosa after two non-ablative Er:YAG laser sessions. The epithelial thickness increased from 45 µm (10-106 µm) to 153 µm (97-244 µm) measured 3 months after the final laser treatment. Vaginal atrophy improved in all patients by all measured outcomes. The degree of patient satisfaction was very high (3.6 on the Likert four-point scale). No adverse events or complications were observed in any of the sessions.
Conclusion: The non-ablative Er:YAG laser seems to be a safe and effective method to increase epithelial thickness of the vaginal mucosa in patients with severe vaginal atrophy.

Entities:  

Keywords:  Genitourinary syndrome of menopause; epithelial thickness; erbium laser; vaginal atrophy; vaginal laser therapy

Mesh:

Year:  2020        PMID: 33124455     DOI: 10.1080/13697137.2020.1764525

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  4 in total

Review 1.  New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.

Authors:  Vittoria Benini; Alessandro Ferdinando Ruffolo; Arianna Casiraghi; Rebecca S Degliuomini; Matteo Frigerio; Andrea Braga; Maurizio Serati; Marco Torella; Massimo Candiani; Stefano Salvatore
Journal:  Medicina (Kaunas)       Date:  2022-06-06       Impact factor: 2.948

2.  Morphological and histological changes in the urethra after intraurethral nonablative erbium YAG laser therapy: an experimental study in beagle dogs.

Authors:  Sheng-Fei Xu; Kuerbanjiang Abulikim; Xiao-Yu Wu; Yu Cheng; Qing Ling; Ke Rao; Kai Cui; Zhong Chen; Guang-Hui Du; Xiao-Yi Yuan
Journal:  Lasers Med Sci       Date:  2022-05-26       Impact factor: 2.555

3.  Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis.

Authors:  Nobuo Okui; Hironari Miyazaki; Wataru Takahashi; Toshihide Miyauchi; Chikako Ito; Machiko Okui; Kaori Shigemori; Yoshiharu Miyazaki; Zdenko Vizintin; Matjaž Lukac
Journal:  Lasers Med Sci       Date:  2021-04-22       Impact factor: 3.161

4.  Nonablative transurethral Erbium:YAG laser treatment for chronic prostatitis/chronic pelvic pain syndrome: A prospective comparative study.

Authors:  Adrián Gaspar; Joaquín Silva; Gustavo Silva; Raúl Anchelerguez; Jorge Prats; Alejandro Sagaz; Eduardo Rovere; Mauricio Alastra; Juan Pino; Alejandro Jauregui; Marcos Farrugia; Fabricio Villaroel; Jonathan Guareschi; Maximiliano Vega; Emanuel Biasiori; Emanuel Moyano; Antonio La Rosa; Irena Hreljac; Zdenko Vižintin
Journal:  Neurourol Urodyn       Date:  2020-11-10       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.